THE INFLUENCE OF POLYTHERAPY ON THE RELATIONSHIPS BETWEEN SERUM CARBAMAZEPINE AND ITS METABOLITES IN EPILEPTIC CHILDREN

被引:0
作者
LIU, H [1 ]
DELGADO, MR [1 ]
机构
[1] UNIV TEXAS,SW MED CTR,TEXAS SCOTTISH RITE HOSP CHILDREN,DEPT NEUROL,DALLAS,TX 75219
关键词
CARBAMAZEPINE; CARBAMAZEPINE EPOXIDE; CARBAMAZEPINE DIOL; VALPROIC ACID; ANTIEPILEPTIC DRUGS; EPILEPTIC CHILDREN;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The influence of polytherapy on the relationships between the age, weight, carbamazepine (CBZ) dose, total clearance, and intrinsic clearance, with concentrations, concentration ratios, and level/dose ratios of CBZ, carbamazepine-10,11-epoxide (CBZ-E) and trans-10,11-dihydroxy-10,11-dihydro-carbamazepine (CBZ-H) are investigated. Three groups of patients with CBZ monotherapy, or receiving CBZ polytherapy by taking CBZ and valproic acid (VPA) or CBZ plus other antiepileptic drugs (AEDs) were studied. The significant correlations between serum CBZ concentrations and CBZ dose in patients taking CBZ alone were no longer significant in patients with polytherapy, and the positive associations between serum CBZ-E concentrations and CBZ dose were lost in patients with CBZ + VPA. Only the concentrations of CBZ-H had significant correlations with CBZ dose in all three groups of patients. Results from this relationship study indicate a heteroinduction effect of other AEDs on CBZ metabolism, and a relatively weak influence on CBZ-E elimination. Data also suggest that there is a block in the biotransformation from CBZ-E to CBZ-H in patients taking CBZ + VPA, presumably caused by the inhibition effect of VPA on epoxide hydrolase. Therapeutic drug monitoring of CBZ will benefit from the knowledge obtained from the relationship study.
引用
收藏
页码:257 / 269
页数:13
相关论文
共 37 条
[1]   FACTORS INFLUENCING SERUM LEVELS OF CARBAMAZEPINE AND CARBAMAZEPINE-10,11-EPOXIDE IN CHILDREN [J].
ALTAFULLAH, I ;
TALWAR, D ;
LOEWENSON, R ;
OLSON, K ;
LOCKMAN, LA .
EPILEPSY RESEARCH, 1989, 4 (01) :72-80
[2]   CLINICAL PHARMACOKINETICS AND PHARMACOLOGICAL EFFECTS OF CARBAMAZEPINE AND CARBAMAZEPINE-10,11-EPOXIDE - AN UPDATE [J].
BERTILSSON, L ;
TOMSON, T .
CLINICAL PHARMACOKINETICS, 1986, 11 (03) :177-198
[3]  
BOURGEOIS BFD, 1984, THER DRUG MONIT, V6, P259, DOI 10.1097/00007691-198409000-00001
[4]  
BOURGEOIS BFD, 1984, J PHARMACOL EXP THER, V231, P411
[5]  
BROWNE TR, 1991, EPILEPSIA, V32, pS66
[6]   NEW PHARMACOKINETIC METHODS .1. ESTIMATION OF MEAN SERUM CONCENTRATION FROM TROUGH SERUM CONCENTRATION [J].
BROWNE, TR ;
GREENBLATT, DJ ;
SZABO, GK ;
EVANS, JE ;
EVANS, BA .
JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (06) :482-488
[7]   CARBAMAZEPINE METABOLISM IN MAN INDUCTION AND PHARMACOGENETIC ASPECTS [J].
EICHELBAUM, M ;
TOMSON, T ;
TYBRING, G ;
BERTILSSON, L .
CLINICAL PHARMACOKINETICS, 1985, 10 (01) :80-90
[8]   FACTORS INFLUENCING SIMULTANEOUS CONCENTRATIONS OF TOTAL AND FREE CARBAMAZEPINE AND CARBAMAZEPINE-10, 11-EPOXIDE IN SERUM OF CHILDREN WITH EPILEPSY [J].
ELYAS, AA ;
PATSALOS, PN ;
AGBATO, OA ;
BRETT, EM ;
LASCELLES, PT .
THERAPEUTIC DRUG MONITORING, 1986, 8 (03) :288-292
[9]  
Faigle JW, 1989, ANTIEPILEPTIC DRUGS, P491
[10]   CARBAMAZEPINE AND CARBAMAZEPINE-10,11-EPOXIDE SERUM CONCENTRATIONS IN EPILEPTIC CHILDREN [J].
FURLANUT, M ;
MONTANARI, G ;
BONIN, P ;
CASARA, GL .
JOURNAL OF PEDIATRICS, 1985, 106 (03) :491-495